Middle
NIAID Launches Universal Flu Vaccine Study
A major research priority for NIAID is finding a universal flu vaccine--one that could durably protect all age groups against multiple influenza strains. NIAID has launched a new study testing a potential vaccine candidate.
Middle
Early-Stage Ebola Treatment Trial Begins
NIAID scientists are evaluating a monoclonal antibody treatment for Ebola in a Phase 1 clinical trial at the NIH Clinical Center.
Middle
New DAIDS RSC Website
The DAIDS Regulatory Support Center (RSC) site has been redesigned. The DAIDS RSC website provides information on regulatory aspects of DAIDS clinical trial operations.
